Mechanisms of interferon beta action in multiple sclerosis

Antel J. , Arnason Bgw , Medof ME (1979) Suppressor cell function in multiple sclerosis: Correlation with disease activity. Ann.Neurol., 5, 338-342.

Arnason BG , Reder AT (1994) Interferons and multiple sclerosis. Clin.Neuropharmacol., 17, 495-547.

Balashov, K.E. , Smith, D.R. , Khoury, S.J. , Hafler, D.A. , and Weiner, H.L. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc. Natl. Acad. Sci. USA, 94, 599-603, 1997.

Baron JL , Mardi JA , Ruddle NH , et al (1993) Surface expression of alpha 4 integrin by CD4 T-cells is required for their entry into brain parenchyma. J Exp Med, 177, 57-68.

Calabresi PA , Tranquill LR , Dambrosia JM , Stone LA , Maloni H. , Bash CN et al. ( 1997) Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-lb . Ann.Neurol., 41, 669-674.

Cieri M. , Bever CT (1990) Gamma interferon (gamma-IFN) induced increases in macrophage cathepsin B activity are blocked by alpha and beta IFN (Type-I-IFN) . FASEB J., 4, A339- Abstract.

Dayal AS , Jensen MA , Lledo A. , Arnason Bgw (1995) Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-lb. Neurology, 45, 2173-2177.

Dhib-Jalbut S. , Jiang H. , Williams GJ (1996) The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion. J.Neuroimmunol., 71, 215-222.

Genc K. , Dona DL , Reder AT (1997) Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy. J Clin Invest , 99,2664-2671.

Hall GL , Compston A. , Scolding NJ (1997) Beta-Interferon and multiple sclerosis. Trends Neurosci., 20, 63-67.

Hohlfeld R. (1997) Biotechnological agents for the immunotherapy of multiple sclerosis, principles, problems and perspectives. Brain, 120, 865-916.

Huynh HK , Oger J. , Dorovini-Zis K. (1995) Interferon-β downregulates IFN-γ- induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells. J Neurimmunol , 60, 63-73.

Jacobs LD , Cookfair DL , Rudick RA , et al. (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann.Neurol., 39, 285-294.

Jiang H. , Milo R. , Swoveland P. , Johnson KP , Panitch H. , Dhib-Jalbut S. (1995) Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells. J.Neuroimmunol. , 61, 17-25.

Jiang H. , Williams GJ , Dhib-Jalbut S. (1997) The effect of interferon beta-1b on cytokine-induced adhesion molecule expression. Neurochem.Int., 30, 449-453.

Joseph J. , Knobler RL , D'Imperio C. , Lubin FD (1988) Down-regulation of interferon-gamma-induced class II expression on human glioma cells by recombinant interferon-beta-effects of dosage treatment shcedule. J.Neuroimmunol., 20, 39-44.

Kolosov M. , Kolosova I. , Leu RW (1996) Stimulation of macrophage synthesis of complement Clq by interferon-gamma mediated by interferon-alpha/beta. J Interferon Cytokine Res.,16, 245-249.

Leppert D. , Waubant E. , Burk MR , Oksenberg JR , Hauser SL (1996) Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis. Ann Neurol, 40, 846-852.

Ling PD , Warren MK , Vogel SN (1985) Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages. J.Immunol. , 135, 1857-1863.

Lu HT , Riley JL , Babcock GT , Huston M. , Stark GR , Boss JM , Ransohoff RM (1995) Interferon beta acts downstream of IFN-γ induced class II transactivator mRNA accumulation to block MHC class II gene expression and requires the 48 kD DNA binding protein, ISGF3-γ. J. Exp. Med., 182, 1517-1525.

Martin R, McFarland HF (1995) Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Critic. Rev. Clin. Lab. Sci., 32, 121-182. McLaurin J, Antel JP, Yong VW (1995) Immune and non-immune actions of Interferon-ß on primary human neural cells. Multiple sclerosis, 1, 10-19.

Miller DH (1994) Magnetic resonance in monitoring the treatment of multiple sclerosis. Ann Neurol, 36, S91-94.

Miller SD , Karpus WJ (1994) The ' immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol Today, 15, 356-361.

Neighbor PA (1979) Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis. Proc.Natl.Acad.Sci. USA, 76, 476-480.

Noronha A. , Toscas A. , Arnason Bgw , Jensen M. (1994) IFN-beta augments in vivo suppressor function in MS. Neurology, 44, A212.

Noronha A. , Toscas A. , Jensen MA (1993) Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis. J.Neuroimmunol. , 46, 145-154.

Pan W. , Banks WA , Kastin AJ (1997) Permeability of the blood-brain and blood-spinal cord barriers to interferons. J. neuroimmunol., 76, 105-111.

Panitch HS , Folus JS , Johnson KP (1987a) Recombinant beta interferon inhibits gamma interferon production in multiple sclerosis. Ann.Neurol., 22, 139, Abstract.

Panitch HS , Folus JS , Johnson KP (1989) Beta interferon prevents HLA class II antigen induction by gamma interferon in MS. Neurology, 39, 171-Abstract.

Panitch HS , Hirsch RL , Haley AS , Johnson KP (1987b) Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet; 1, 893-895.

Ransohoff RM , et al., (1991) Interferon-beta specifically inhibits interferon-gamma induced class II major histocompatability complex gene transcription in a human astrocytoma cell line. J.Neuroimmunol., 33, 103-112.

Rudick RA , Carpenter CS , Cookfair DL , Tuohy VK , Ransohoff RM (1993) In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta. Neurology , 43, 2080-2087.

Rudick RA , Ransohoff RM , Peppier R. , VanderBurg Medendorp S. , Lehmann P. , Alam J. ( 1996) Intrferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann. Neurol., 40, 618-627.

Selmaj KW , Raine CS (1988) Tumor necrosis factor mediates nyelin and oligodendrocyte damage in multiple sclerosis brain. Ann neurol, 23, 339-346.

Sibley WA , Bamford CR , Clark K. (1985) Clinical viral infections and multiple sclerosis . Lancet, 1.

Soilu-Hanninen M. , Salmi A. , Salonen R. (1995) Interferon-beta downregulates expression of VLA-4 antigen and antagonizes interferon-gamma induced expression of HLA-DQ in human peripheral blood monocytes. J. Neuroimmunol., 60, 99-106.

Stone LA , Frank JA , Albert PS , Bash C. , Smith ME , Maloni H. , McFarland HF ( 1995) The effect of interferon-beta on blood-brain barrier disruption demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann.Neurol., 37, 611-619.

Stuve 0 , Dooley NP , Uhm JH , Antel JP , Francis GS , Williams G. , Yong VW ( 1996) Interferon beta-1b decreases the migration of T lymphocytes in vitro: Effects on Matrix Metalloproteinase-9. Ann neurol , 40, 853-863.

Svenningsson A. , Hansson G. , Andersen O. , Andersson R. , Patarroyo M. , Stemme S. ( 1993) Adhesion molecule expression on cerebrospinal fluid T-lymphocytes in multiple sclerosis, aseptic meningitis, and normal controls. Ann Neurol, 34, 155-161.

The IFNB multiple sclerosis study group (1993 ). Interferon beta 1b is effective in relapsing remitting multiple sclerosis: Clinical results of A multicenter randomized double blind, placebo controlled trial. Neurology, 43, 655-661.

Traugott U. , Lebon B. (1988) Demonstration of alpha, beta and gamma interferon in active chronic multiple sclerosis. In: Advances in Neuroimmunology., Volume 540. Edited by C. S. Raine, ed.: Ann.NY.Acad.Sci., pp. 309-311.

Vervliet G. , Carton H. , Meulepas E. , Billiau A. (1984) Interferon production by cultured peripheral leukocytes of MS patients. Clin.Exp.lmmunol., 58, 116-126.